RAPP
Price
$36.99
Change
+$2.09 (+5.99%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.77B
63 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$4.83
Change
-$0.17 (-3.41%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
2.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

RAPP vs SLXN

Header iconRAPP vs SLXN Comparison
Open Charts RAPP vs SLXNBanner chart's image
RAPP vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RAPP vs. SLXN commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAPP is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (RAPP: $34.85 vs. SLXN: $4.86)
Brand notoriety: RAPP and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RAPP: 93% vs. SLXN: 13%
Market capitalization -- RAPP: $1.77B vs. SLXN: $2.09M
RAPP [@Biotechnology] is valued at $1.77B. SLXN’s [@Biotechnology] market capitalization is $2.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RAPP’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • RAPP’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, RAPP is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPP’s TA Score shows that 2 TA indicator(s) are bullish while SLXN’s TA Score has 6 bullish TA indicator(s).

  • RAPP’s TA Score: 2 bullish, 7 bearish.
  • SLXN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than RAPP.

Price Growth

RAPP (@Biotechnology) experienced а -12.24% price change this week, while SLXN (@Biotechnology) price change was +16.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

RAPP is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($1.77B) has a higher market cap than SLXN($2.09M). RAPP has higher P/E ratio than SLXN: RAPP (21.81) vs SLXN (0.00). RAPP YTD gains are higher at: 21.918 vs. SLXN (-74.687). SLXN has higher annual earnings (EBITDA): -12.91M vs. RAPP (-121.21M). SLXN has less debt than RAPP: SLXN (2.04M) vs RAPP (10.8M). RAPP has higher revenues than SLXN: RAPP (20M) vs SLXN (0).
RAPPSLXNRAPP / SLXN
Capitalization1.77B2.09M84,601%
EBITDA-121.21M-12.91M939%
Gain YTD21.918-74.687-29%
P/E Ratio21.810.00529,072%
Revenue20M0-
Total Cash477MN/A-
Total Debt10.8M2.04M530%
TECHNICAL ANALYSIS
Technical Analysis
RAPPSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
34%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
41%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
31%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 2 days ago
54%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
RAPP
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQST4.030.10
+2.54%
Aquestive Therapeutics
AUC7.940.08
+1.05%
ATIF Holdings Limited.
FRPT50.000.14
+0.28%
Freshpet
DOC19.07-0.38
-1.95%
Healthpeak Properties
TRUG1.59-0.04
-2.16%
TruGolf Holdings Inc.

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with ACRV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then ACRV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+5.99%
ACRV - RAPP
36%
Loosely correlated
-2.87%
PRAX - RAPP
35%
Loosely correlated
+7.95%
FTRE - RAPP
35%
Loosely correlated
+1.82%
MLTX - RAPP
34%
Loosely correlated
+2.24%
BCAX - RAPP
31%
Poorly correlated
+1.88%
More